James Meek
Research Subjects
James Meek has a total of 82 co-authors. Here are the top co-authors by number of shared publications:
- Alison F. Hinckley
Division of Vector-Borne Diseases, Centers for Disease Control and Prevention, Fort Collins, CO, USA
5 shared publications - AmberJean P. Hansen
Connecticut Emerging Infections Program, Yale School of Public Health, New Haven, CT, USA
5 shared publications - Sara A. Niesobecki
Department of Biology, Western Connecticut State University, Danbury, Connecticut (Ms Hornbostel and Dr Connally); Connecticut Emerging Infections Program, Yale School of Public Health, New Haven, Connecticut (Mr Meek and Mss Hansen and Niesobecki); and Division of Vector-Borne Disease, Centers for Disease Control and Prevention, Fort Collins, Colorado (Ms Nawrocki and Dr Hinckley)
3 shared publications - Courtney C. Nawrocki
Division of Vector-Borne Diseases, US Centers for Disease Control and Prevention, Fort Collins, CO, United States
2 shared publications - David B. Banach
University of Connecticut School of Medicine
2 shared publications - Heather Rutz
Maryland Department of Health , Baltimore, MD
2 shared publications
Latest Publications
- 24 September 2024
- Published by Wolters Kluwer Health in Journal of Public Health Management & Practice
- Vol. 31 (1) , E52-E60
Barriers to the Uptake of Tickborne Disease Prevention Measures: Connecticut, Maryland 2016-2017
Context: Public health programs promote numerous tickborne disease (TBD) prevention measures. However, measures are not frequently or consistently performed. Objective: Describe barriers to consistent use of 4 commonly promoted TBD prevention measures. Design: We conducted an online survey (n = 1883) evaluating behaviors regarding TBD prevention measures including conducting tick checks, applying insect repellents, showering/bathing, and applying chemical or natural pesticides to residential yards. Respondents could select reasons for never, rarely, or sometimes performing these measures. Descriptive analysis and logistic regression modeling evaluated associations between the 3 most cited barriers for each measure and select demographic variables. Setting: The survey was administered to residents in high Lyme disease incidence counties of Connecticut and Maryland, 2016-2017. Results: For tick checks (n = 800), the most cited barriers were forgetting (63%), not spending time in tick habitat (28%), and too much trouble (11%). For applying insect repellents (n = 1303), the most cited barriers were forgetting (38%), personal safety concerns (24%), and too much trouble (19%). For showering/bathing 2 hours after outdoor activity in tick habitat (n = 1080), the most cited barriers were being unaware of the prevention measure (51%), too much trouble (18%), and forgetting (18%). For applying chemical pesticides to yards (n = 1320), the most cited barriers were having environmental (45%), pet safety (31%), and personal safety concerns (28%). Lastly, for applying natural pesticides to yards (n = 1357), the most cited barriers were being unaware of natural pesticides (31%), having cost concerns (23%), and not being concerned about ticks on property (16%). Conclusions: Forgetting, too much trouble, unawareness, and safety concerns were primary barriers to using several TBD prevention measures. Education regarding effectiveness, safety, and timing may increase uptake of certain measures. These challenges can be difficult to address, highlighting the need for passive TBD prevention measures, such as a Lyme disease vaccine.
- 24 September 2024
- Published by Wolters Kluwer Health in Journal of Public Health Management & Practice
- Vol. 31 (1) , E52-E60
Barriers to the Uptake of Tickborne Disease Prevention Measures: Connecticut, Maryland 2016-2017
Context: Public health programs promote numerous tickborne disease (TBD) prevention measures. However, measures are not frequently or consistently performed. Objective: Describe barriers to consistent use of 4 commonly promoted TBD prevention measures. Design: We conducted an online survey (n = 1883) evaluating behaviors regarding TBD prevention measures including conducting tick checks, applying insect repellents, showering/bathing, and applying chemical or natural pesticides to residential yards. Respondents could select reasons for never, rarely, or sometimes performing these measures. Descriptive analysis and logistic regression modeling evaluated associations between the 3 most cited barriers for each measure and select demographic variables. Setting: The survey was administered to residents in high Lyme disease incidence counties of Connecticut and Maryland, 2016-2017. Results: For tick checks (n = 800), the most cited barriers were forgetting (63%), not spending time in tick habitat (28%), and too much trouble (11%). For applying insect repellents (n = 1303), the most cited barriers were forgetting (38%), personal safety concerns (24%), and too much trouble (19%). For showering/bathing 2 hours after outdoor activity in tick habitat (n = 1080), the most cited barriers were being unaware of the prevention measure (51%), too much trouble (18%), and forgetting (18%). For applying chemical pesticides to yards (n = 1320), the most cited barriers were having environmental (45%), pet safety (31%), and personal safety concerns (28%). Lastly, for applying natural pesticides to yards (n = 1357), the most cited barriers were being unaware of natural pesticides (31%), having cost concerns (23%), and not being concerned about ticks on property (16%). Conclusions: Forgetting, too much trouble, unawareness, and safety concerns were primary barriers to using several TBD prevention measures. Education regarding effectiveness, safety, and timing may increase uptake of certain measures. These challenges can be difficult to address, highlighting the need for passive TBD prevention measures, such as a Lyme disease vaccine.
- Open Access
- 27 November 2023
- Published by Oxford University Press (OUP) in Open Forum Infectious Diseases
- Vol. 10 (Supplement)
841. An Evaluation of Outcomes and Hospital Readmissions Among Individuals with Candidemia in Connecticut (2019-2020)
In addition to significant morbidity and mortality, sepsis is a leading cause of hospital readmission. Candidemia, a leading cause of sepsis, has a particularly high morbidity and mortality rate. Previous studies defined risk factors for poor outcomes and readmission after general sepsis. However, specific risk factors for readmission after candidemia are unknown. The study is retrospective cohort study of adults in Connecticut with an episode of candidemia between 2019-2022 using statewide surveillance data. Individuals were classified based on primary outcome (died versus survived) at incident admission. Candidemia survivors were further classified by readmission status. A descriptive analysis of demographics, healthcare related factors, and readmission characteristics was performed in univariate and multivariate analyses to identify factors associated with mortality and readmission after an episode of candidemia. Demographic and clinical factors of incident case outcome and readmissions, 2019-2020 (Abbreviated). Multivariate analysis for age and class of infection by incident case outcome and readmission status Individuals with candidemia have a high risk of mortality and readmission. Individuals with hospital-onset infection are at particularly high risk of mortality and subsequent readmission. Efforts to prevent hospital-onset candidemia are critical. Additional measures focused on individuals with risk factors for readmission are needed to reduce overall morbidity and mortality associated with candidemia. All Authors: No reported disclosures
- 27 November 2023
- Published by Oxford University Press (OUP) in Open Forum Infectious Diseases
- Vol. 10 (Supplement)
Open Access841. An Evaluation of Outcomes and Hospital Readmissions Among Individuals with Candidemia in Connecticut (2019-2020)
In addition to significant morbidity and mortality, sepsis is a leading cause of hospital readmission. Candidemia, a leading cause of sepsis, has a particularly high morbidity and mortality rate. Previous studies defined risk factors for poor outcomes and readmission after general sepsis. However, specific risk factors for readmission after candidemia are unknown. The study is retrospective cohort study of adults in Connecticut with an episode of candidemia between 2019-2022 using statewide surveillance data. Individuals were classified based on primary outcome (died versus survived) at incident admission. Candidemia survivors were further classified by readmission status. A descriptive analysis of demographics, healthcare related factors, and readmission characteristics was performed in univariate and multivariate analyses to identify factors associated with mortality and readmission after an episode of candidemia. Demographic and clinical factors of incident case outcome and readmissions, 2019-2020 (Abbreviated). Multivariate analysis for age and class of infection by incident case outcome and readmission status Individuals with candidemia have a high risk of mortality and readmission. Individuals with hospital-onset infection are at particularly high risk of mortality and subsequent readmission. Efforts to prevent hospital-onset candidemia are critical. Additional measures focused on individuals with risk factors for readmission are needed to reduce overall morbidity and mortality associated with candidemia. All Authors: No reported disclosures
- Open Access
- 27 November 2023
- Published by Oxford University Press (OUP) in Open Forum Infectious Diseases
- Vol. 10 (Supplement)
2466. The Evolution of Candidemia during the COVID-19 Pandemic in Connecticut
Candidemia is a life-threatening bloodstream infection. The changing epidemiology of candidemia during the COVID-19 pandemic has not been well described. The goal of this study is to describe trends in candidemia epidemiology throughout various phases of the COVID-19 pandemic in Connecticut. Using statewide surveillance we identified all adult Connecticut residents with candidemia between January 2020 and October 2022. Cases were aggregated by four-month intervals. Three surges of COVID-19 (Initial, Delta, and Omicron variant surges) were identified based on statewide COVID-19 case numbers. Incidence rate ratios (IRR) were calculated to compare the incidence rate (IR) of candidemia during surge periods to the IR of candidemia in non-surge periods (four-month intervals before and after surges). Patient demographics and clinical characteristics were compared using chi-square analysis. We identified an association between COVID-19 surges and increased rates of candidemia. Candidemia cases during surge periods occurred more frequently among non-white persons, were more likely to have hospital-onset and were more severe suggesting that COVID-19 treatments or interventions may have impacted candidemia rates. Further study is needed to understand factors that resulted in different IRs of candidemia during various phases of the COVID-19 pandemic to inform strategies to prevent candidemia during future public health crises. All Authors: No reported disclosures
- 27 November 2023
- Published by Oxford University Press (OUP) in Open Forum Infectious Diseases
- Vol. 10 (Supplement)
Open Access2466. The Evolution of Candidemia during the COVID-19 Pandemic in Connecticut
Candidemia is a life-threatening bloodstream infection. The changing epidemiology of candidemia during the COVID-19 pandemic has not been well described. The goal of this study is to describe trends in candidemia epidemiology throughout various phases of the COVID-19 pandemic in Connecticut. Using statewide surveillance we identified all adult Connecticut residents with candidemia between January 2020 and October 2022. Cases were aggregated by four-month intervals. Three surges of COVID-19 (Initial, Delta, and Omicron variant surges) were identified based on statewide COVID-19 case numbers. Incidence rate ratios (IRR) were calculated to compare the incidence rate (IR) of candidemia during surge periods to the IR of candidemia in non-surge periods (four-month intervals before and after surges). Patient demographics and clinical characteristics were compared using chi-square analysis. We identified an association between COVID-19 surges and increased rates of candidemia. Candidemia cases during surge periods occurred more frequently among non-white persons, were more likely to have hospital-onset and were more severe suggesting that COVID-19 treatments or interventions may have impacted candidemia rates. Further study is needed to understand factors that resulted in different IRs of candidemia during various phases of the COVID-19 pandemic to inform strategies to prevent candidemia during future public health crises. All Authors: No reported disclosures
- 9 August 2023
- Published by Wolters Kluwer Health in Journal of Public Health Management & Practice
- Vol. 30 (1) , 111-121
Operational Considerations for Using Deer-Targeted 4-Poster Tick Control Devices in a Tick-borne Disease Endemic Community
Context: In the northeastern United States, recommendations to prevent diseases spread by black-legged ticks (Ixodes scapularis) and lone star ticks (Amblyomma americanum) often rely on individuals to use personal protection or yard-based strategies. The 4-Poster deer treatment stations (4-Posters) suppress tick populations by treating deer hosts with acaricide, potentially offering a community-wide approach for reducing tick-borne diseases in endemic areas. The 4-Poster deployment logistics in mainland community settings are not well documented but are needed for future public health tick control efforts. Program: As part of a public health research effort to design a population-based 4-Poster effectiveness study aimed at reducing tick-borne disease incidence, TickNET researchers partnered with the Town of Ridgefield (Connecticut) to understand the feasibility and operational logistics of deploying 4-Posters on public land within a residential community to inform future public health interventions by municipalities or vector control agencies. Implementation: We deployed three 4-Posters on a municipal property from July to December 2020 and used motion-activated cameras to record wildlife activity nearby. We documented per-device operational details, costs, materials consumed, and animal activity. Evaluation: Operation of 4-Posters was feasible, and device challenges were easily remedied. Deer visitation and heavy nontarget animal use were documented at all devices. Unexpectedly, monthly corn consumption was not correlated with monthly deer-view days. The monthly cost per device was US $1279 or US $305 per hectare with an average 21 minutes of weekly service time. Discussion: Use of 4-Posters by communities, public health agencies, or vector control programs may be a practicable addition to tick management programs in tick-borne disease endemic areas in the Northeast. Such programs should carefully consider local and state regulations, follow manufacturer and pesticide label guidelines, and include wildlife monitoring. High labor costs incurred in this project could be mitigated by training vector control agency or municipality staff to service 4-Posters.
- 9 August 2023
- Published by Wolters Kluwer Health in Journal of Public Health Management & Practice
- Vol. 30 (1) , 111-121
Operational Considerations for Using Deer-Targeted 4-Poster Tick Control Devices in a Tick-borne Disease Endemic Community
Context: In the northeastern United States, recommendations to prevent diseases spread by black-legged ticks (Ixodes scapularis) and lone star ticks (Amblyomma americanum) often rely on individuals to use personal protection or yard-based strategies. The 4-Poster deer treatment stations (4-Posters) suppress tick populations by treating deer hosts with acaricide, potentially offering a community-wide approach for reducing tick-borne diseases in endemic areas. The 4-Poster deployment logistics in mainland community settings are not well documented but are needed for future public health tick control efforts. Program: As part of a public health research effort to design a population-based 4-Poster effectiveness study aimed at reducing tick-borne disease incidence, TickNET researchers partnered with the Town of Ridgefield (Connecticut) to understand the feasibility and operational logistics of deploying 4-Posters on public land within a residential community to inform future public health interventions by municipalities or vector control agencies. Implementation: We deployed three 4-Posters on a municipal property from July to December 2020 and used motion-activated cameras to record wildlife activity nearby. We documented per-device operational details, costs, materials consumed, and animal activity. Evaluation: Operation of 4-Posters was feasible, and device challenges were easily remedied. Deer visitation and heavy nontarget animal use were documented at all devices. Unexpectedly, monthly corn consumption was not correlated with monthly deer-view days. The monthly cost per device was US $1279 or US $305 per hectare with an average 21 minutes of weekly service time. Discussion: Use of 4-Posters by communities, public health agencies, or vector control programs may be a practicable addition to tick management programs in tick-borne disease endemic areas in the Northeast. Such programs should carefully consider local and state regulations, follow manufacturer and pesticide label guidelines, and include wildlife monitoring. High labor costs incurred in this project could be mitigated by training vector control agency or municipality staff to service 4-Posters.
- Open Access
- 31 July 2023
- Published by Elsevier in Ticks and Tick-borne Diseases
- Vol. 14 (6) , 102231
Acceptability of 4-poster deer treatment devices for community-wide tick control among residents of high Lyme disease incidence counties in Connecticut and New York, USA
- 31 July 2023
- Published by Elsevier in Ticks and Tick-borne Diseases
- Vol. 14 (6) , 102231
Open AccessAcceptability of 4-poster deer treatment devices for community-wide tick control among residents of high Lyme disease incidence counties in Connecticut and New York, USA
- 1 May 2020
- Published by Elsevier in American Journal of Preventive Medicine
- Vol. 58 (5) , e149-e157
Human Papillomavirus 16/18–Associated Cervical Lesions: Differences by Area-Based Measures of Race and Poverty
- 1 May 2020
- Published by Elsevier in American Journal of Preventive Medicine
- Vol. 58 (5) , e149-e157
Human Papillomavirus 16/18–Associated Cervical Lesions: Differences by Area-Based Measures of Race and Poverty
- 1 October 2019
- Published by Elsevier in Ticks and Tick-borne Diseases
- Vol. 10 (6) , 101264
Knowledge, attitudes, and behaviors regarding tick-borne disease prevention in endemic areas
- 1 October 2019
- Published by Elsevier in Ticks and Tick-borne Diseases
- Vol. 10 (6) , 101264
Knowledge, attitudes, and behaviors regarding tick-borne disease prevention in endemic areas
- Open Access
- 26 August 2015
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 15 (1) , 1-9
Pneumonia among adults hospitalized with laboratory-confirmed seasonal influenza virus infection—United States, 2005–2008
Influenza and pneumonia combined are the leading causes of death due to infectious diseases in the United States. We describe factors associated with pneumonia among adults hospitalized with influenza. Through the Emerging Infections Program, we identified adults ≥ 18 years, who were hospitalized with laboratory-confirmed influenza during October 2005 through April 2008, and had a chest radiograph (CXR) performed. Pneumonia was defined as the presence of a CXR infiltrate and either an ICD-9-CM code or discharge summary diagnosis of pneumonia. Among 4,765 adults hospitalized with influenza, 1392 (29 %) had pneumonia. In multivariable analysis, factors associated with pneumonia included: age ≥ 75 years, adjusted odds ratio (AOR) 1.27 (95 % confidence interval 1.10–1.46), white race AOR 1.24 (1.03–1.49), nursing home residence AOR 1.37 (1.14–1.66), chronic lung disease AOR 1.37 (1.18–1.59), immunosuppression AOR 1.45 (1.19–1.78), and asthma AOR 0.76 (0.62–0.92). Patients with pneumonia were significantly more likely to require intensive care unit (ICU) admission (27 % vs. 10 %), mechanical ventilation (18 % vs. 5 %), and to die (9 % vs. 2 %). Pneumonia was present in nearly one-third of adults hospitalized with influenza and was associated with ICU admission and death. Among patients hospitalized with influenza, older patients and those with certain underlying conditions are more likely to have pneumonia. Pneumonia is common among adults hospitalized with influenza and should be evaluated and treated promptly.
- 26 August 2015
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 15 (1) , 1-9
Open AccessPneumonia among adults hospitalized with laboratory-confirmed seasonal influenza virus infection—United States, 2005–2008
Influenza and pneumonia combined are the leading causes of death due to infectious diseases in the United States. We describe factors associated with pneumonia among adults hospitalized with influenza. Through the Emerging Infections Program, we identified adults ≥ 18 years, who were hospitalized with laboratory-confirmed influenza during October 2005 through April 2008, and had a chest radiograph (CXR) performed. Pneumonia was defined as the presence of a CXR infiltrate and either an ICD-9-CM code or discharge summary diagnosis of pneumonia. Among 4,765 adults hospitalized with influenza, 1392 (29 %) had pneumonia. In multivariable analysis, factors associated with pneumonia included: age ≥ 75 years, adjusted odds ratio (AOR) 1.27 (95 % confidence interval 1.10–1.46), white race AOR 1.24 (1.03–1.49), nursing home residence AOR 1.37 (1.14–1.66), chronic lung disease AOR 1.37 (1.18–1.59), immunosuppression AOR 1.45 (1.19–1.78), and asthma AOR 0.76 (0.62–0.92). Patients with pneumonia were significantly more likely to require intensive care unit (ICU) admission (27 % vs. 10 %), mechanical ventilation (18 % vs. 5 %), and to die (9 % vs. 2 %). Pneumonia was present in nearly one-third of adults hospitalized with influenza and was associated with ICU admission and death. Among patients hospitalized with influenza, older patients and those with certain underlying conditions are more likely to have pneumonia. Pneumonia is common among adults hospitalized with influenza and should be evaluated and treated promptly.